US FDA approves Lilly’s once-weekly insulin injection for type 2 diabetes
AI Summary
The US Food and Drug Administration (FDA) has approved Lilly's once-weekly insulin injection for treatment of type 2 diabetes, marking an advancement in diabetes management. This approval is poised to improve patient convenience and adherence.